| Date | Title | Description |
| 18.03.2024 | Abcam appoints Markus Lusser as new President | CAMBRIDGE, England, March 18, 2024 /PRNewswire/ -- Abcam today announced the appointment of Markus Lusser as President.
Markus Lusser, President of Abcam
A seasoned Danaher executive, Markus joins Abcam at a pivotal moment as the company tr... |
| 29.08.2023 | Danaher to acquire Abcam - valuing the Cambridge company at $5.7bn | Cambridge, UK / Waltham, MA - Abcam plc, a global leader in the supply of life science research tools, announces that it has entered into a definitive agreement pursuant to which Danaher Corporation will acquire all of the outstanding share... |
| 12.12.2022 | Abcam plc: Update on AIM Delisting | CAMBRIDGE, England and WALTHAM, Mass., Dec. 12, 2022 /PRNewswire/ -- Abcam plc, ABC and ABCM ("Abcam" or the "Company"), a global leader in the supply of life science research tools, today provides a further update with ... |
| 27.06.2022 | Abcam: Appointment of Vice President of Investor Relations | CAMBRIDGE, England, June 27, 2022 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment... |
| 25.03.2022 | Abcam the most awarded company at 2022 industry awards | CAMBRIDGE, England, March 25, 2022 /PRNewswire/ -- Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This r... |
| 13.01.2022 | Abcam in Glassdoor’s top 5 ‘best places to work in the UK’ for second consecutive year | Abcam in Glassdoor’s top 5 ‘best places to work in the UK’ for second consecutive year
13-01-2022
Abcam, a global innovator empowering life science researchers with high-quality biological reagents and tools critical to research, drug disco... |
| 02.11.2021 | Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome | SEATTLE and CAMBRIDGE, England, Nov. 2, 2021 /PRNewswire/ -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, and Abcam (AIM... |
| 02.08.2021 | Abcam to acquire BioVision for $340 million | Abcam to acquire BioVision for $340 million
02-08-2021
Abcam plc (AIM LSE: ABC; Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces that it has entered into a definitive agreement to acquire BioVisio... |
| 14.07.2021 | Abcam opens new US facility in Boston, MA | Abcam opens new US facility in Boston, MA
14-07-2021
Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, announces the opening of a major new site in Waltham, MA.
The new facility is a central component of ... |
| 13.07.2021 | Abcam : opens new US facility in Boston, MA | CAMBRIDGE, July 13, 2021 /PRNewswire/ -- Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA.
The new facility is a central component of Abc... |
| 08.03.2021 | Abcam reports 8.3% constant currency revenue growth in H1 as customers gradually return to labs | Abcam reports 8.3% constant currency revenue growth in H1 as customers gradually return to labs
08-03-2021
Abcam plc (Nasdaq: ABCM; AIM: ABC), a global leader in the supply of life science research tools, today announces its interim results... |
| 25.02.2021 | Slone Partners Places Mark Capone as Non-Executive Board Member at Abcam | “Mark Capone is a tremendously accomplished and respected leader in molecular diagnostics, biotechnology, and product development,” said Slone Partners President Tara Kochis-Stach.
SOUTH RIDING, Va. (PRWEB) February 25, 2021
Slone Partners,... |
